NIH-funded research R01 grant

Which alcohol use disorder treatment will work best for you

Official title: Predicting individual responses to treatment for alcohol use disorder.

Funded at University of New Mexico · NIH-11414952 · Data updated 2026-11-12

This project uses data from past clinical trials and machine learning to predict how well different treatments for alcohol use disorder might work for individual patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of New Mexico
NIH-funded
Lab location1 site (Albuquerque, United States)
Project startApril 20, 2023
Project endMarch 31, 2028
Funding year2026
Award (this year)$660,967
NIH project number5R01AA030264-04
Project IDNIH-11414952 on NIH RePORTER

Who could benefit from this research

Could help

Adults with alcohol use disorder—especially those with recent heavy drinking or considering behavioral or medication treatment—would be the primary group who could benefit from these findings.

Less likely to help

People without alcohol use disorder, those needing urgent medical detox or inpatient care, or individuals with conditions not represented in the original trials may not benefit from these predictions.

What this research studies

If you have alcohol use disorder, this project combines data from 11 past randomized trials—six behavioral relapse-prevention programs and five medication trials—to learn which types of people did better with which treatments. The team trains and cross-validates machine-learning algorithms to make individualized predictions of treatment response and to estimate uncertainty around those predictions. They will test methods for pooling data across trials and improving prediction precision so results can be useful in clinical care. At the end they will publish algorithms that compare expected outcomes for different treatment options for new individuals.

Why it matters

Potential benefit: If successful, this work could help match people with alcohol use disorder to treatments they are most likely to benefit from, reducing trial-and-error and potentially lowering relapse.

How similar studies have gone: Early studies applying machine learning to clinical trial data for AUD and other psychiatric conditions have shown promise but have not yet produced widely used clinical decision tools.

Where this research is happening

  • University of New Mexico
    Albuquerque, United States
    Active

Researchers

  • Principal investigator: Van Horn, M Lee — University of New Mexico
  • Study coordinator: Van Horn, M Lee

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.